Indication
CCR5 tropic HIV infection
CCR5-tropic HIV infection is a human immunodeficiency virus infection characterized specifically by viral strains (termed R5-tropic) that rely exclusively on the host C-C chemokine receptor type 5 (CCR5) as a coreceptor alongside CD4 for cellular entry. Read more about CCR5 tropic HIV infection
9 drugs 7 manufacturers
Drugs that treat it
Common CCR5 tropic HIV infection therapies.
SELZENTRY (maraviroc)
MARAVIROC
SELZENTRY (maraviroc)
MARAVIROC
MARAVIROC
MARAVIROC
MARAVIROC
MARAVIROC
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonCCR5-tropic HIV infection is a human immunodeficiency virus infection characterized specifically by viral strains (termed R5-tropic) that rely exclusively on the host C-C chemokine receptor type 5 (CCR5) as a coreceptor alongside CD4 for cellular entry.
This viral phenotype primarily targets the human immune system, specifically infecting CD4+ T lymphocytes, macrophages, and dendritic cells, and it represents the predominant form of HIV involved in initial transmission and early-stage disease.
Clinically defined through phenotypic or genotypic tropism assays confirming the absence of CXCR4-using or dual/mixed-tropic virus, this specific clinical state identifies patients whose infection can be selectively targeted by host-directed viral entry inhibitors.
- hiv.gov
CCR5-tropic HIV infection is a human immunodeficiency virus infection characterized specifically by viral strains (termed R5-tropic) that rely exclusively on the host C-C chemokine receptor type 5 (CCR5) as a coreceptor alongside CD4 for cellular entry This viral phenotype primarily targets the human immune system, specifically infecting CD4+ T lymphocytes, macrophages, and dendritic cells, and it represents the predominant form of HIV involved in initial transmission and early-stage disease
- nih.gov
This viral phenotype primarily targets the human immune system, specifically infecting CD4+ T lymphocytes, macrophages, and dendritic cells, and it represents the predominant form of HIV involved in initial transmission and early-stage disease
- nih.gov
This viral phenotype primarily targets the human immune system, specifically infecting CD4+ T lymphocytes, macrophages, and dendritic cells, and it represents the predominant form of HIV involved in initial transmission and early-stage disease
- nih.gov
Clinically defined through phenotypic or genotypic tropism assays confirming the absence of CXCR4-using or dual/mixed-tropic virus, this specific clinical state identifies patients whose infection can be selectively targeted by host-directed viral entry inhibitors
- nih.gov
Clinically defined through phenotypic or genotypic tropism assays confirming the absence of CXCR4-using or dual/mixed-tropic virus, this specific clinical state identifies patients whose infection can be selectively targeted by host-directed viral entry inhibitors
Personalize your experience
Follow CCR5 tropic HIV infection and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.